Vimarsana
Biggest News Aggregation in the World

Page 46 - Mobile Android News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mobile Android. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mobile Android Today - Breaking & Trending Today

Lacosamide safe, effective for childhood epilepsy with centrotemporal spikes - Vimarsana News

Lacosamide safe, effective for childhood epilepsy with centrotemporal spikes

Lacosamide monotherapy for the treatment of childhood epilepsy with centrotemporal spikes was well tolerated and resulted in significantly reduced seizures, according to a study published in Brain and Development. “Childhood epilepsy with centrotemporal spikes is an age-limited epilepsy syndrome,” Tohru Okanishi, MD, PhD, associate professor of child neurology at Tottori University in

Source: healio.com
Boy has possible rare form of neurofibromatosis — which infections pose a threat? - Vimarsana News

Boy has possible rare form of neurofibromatosis — which infections pose a threat?

An 8-year-old boy was seen collecting money by dancing in the street in the Central African country of the Democratic Republic of the Congo, or DRC.

Source: healio.com
Black patients 'not caught up' to whites in early-onset CRC survival over 20-year period - Vimarsana News

Black patients 'not caught up' to whites in early-onset CRC survival over 20-year period

SAN DIEGO — Five-year relative survival for early-onset colorectal cancer improved over a 20-year period only among white patients, with no improvements for Black, Asian or Hispanic patients, per data at Digestive Disease Week 2022.“Our most stunning finding was that even over a 20-year span, Blacks had not caught up to whites in surviving early-onset CRC,” Timothy A. Zaki, MD,

Source: healio.com
Low-cost scoring system informs HBV treatment eligibility in resource-limited countries - Vimarsana News

Low-cost scoring system informs HBV treatment eligibility in resource-limited countries

SAN DIEGO — A new, low-cost scoring system called TREAT-B accurately determined treatment eligibility for patients with hepatitis B virus, particularly where DNA assays are unavailable, according to research. “Major international guidelines have recommended the criteria for initiating treatment in patients with chronic hepatitis B infection. However, the hepatitis B DNA assay is not

Source: healio.com
Post-treatment liver stiffness predicts complications, HCC in hepatitis C - Vimarsana News

Post-treatment liver stiffness predicts complications, HCC in hepatitis C

SAN DIEGO — Liver stiffness assessment predicted liver-related complications and hepatocellular carcinoma development among patients with hepatitis C following direct-acting antiviral treatment, according to research. “HCV infection is one of the leading causes of cirrhosis, HCC and liver-related complications. Sustained virological response is achieved in 80% to 95% of chronic HCV

Source: healio.com